Skip to main content
. Author manuscript; available in PMC: 2012 Sep 1.
Published in final edited form as: Bone. 2011 May 15;49(3):356–367. doi: 10.1016/j.bone.2011.05.008

Table 4.

Half-maximal inhibitory concentration of paclitaxel for canine osteosarcoma cell lines from Branch A and Branch B in vitro

Cell Line Paclitaxel IC50 (ng/ml)
U937 (human leukemia) 1
HL-60 (human leukemia) 25
K562 (human leukemia) 20
OSCA-19 (Branch A) 10,000
OSCA-25 (Branch A) NR*
OSCA-71 (Branch A) 15
OSCA-17 (Branch B) 10,000
OSCA-23 (Branch B) NR
OSCA-32 (Branch B) 30,000
*

NR = not reached (>50,000)